October 06, 2011
New York, October 06, 2011
Moelis & Company, the New York-headquartered global independent investment bank, today announced the appointment of Steven Meehan as a Managing Director in Healthcare Investment Banking. Based in New York, Mr. Meehan will provide strategic advice to global healthcare clients.
Ken Moelis, Chief Executive Officer of Moelis & Company, said, “Given the rapidly changing regulatory environment and the aging population, healthcare will be among the most active industry sectors for the foreseeable future. Our clients will be well served by Steven’s almost two decades of healthcare investment banking experience.”
Mr. Meehan joins Moelis & Company from UBS Investment Bank where he was most recently CEO of UBS Russia and CIS across all businesses including securities, investment banking and wealth management. He was also a member of the UBS Group Europe, Middle East, Africa Management Committee. He joined the bank in 1999 as part of the team that formed the Global Healthcare Group as Head of Life Sciences. During his investment banking career he has held senior roles at Salomon Smith Barney, NatWest Securities and Drexel Burnham Lambert.
Mr. Moelis added, “Steven’s appointment builds on our existing healthcare coverage further ensuring that we are providing clients with world-class independent advice and solutions in this important sector.”
About Moelis & Company
Moelis & Company is a global investment bank that provides financial advisory, capital raising and asset management services to a broad client base including corporations, institutions and governments. With more than 570 employees, Moelis & Company serves its clients through offices in New York, Boston, Chicago, Dubai, Hong Kong, Houston, London, Los Angeles and Sydney. For more information, please visit www.moelis.com.
1 212 883 3666